Want to join the conversation?
$AGN, a global pharmaceutical company, announces the launch of a generic version of Janssen's INVEGA (paliperidone extended-release tablets) in the U.S. $AGN is the first to receive the FDA approval for generic version of INVEGA. INVEGA extended-release tablets are used for the treatment of schizophrenia in adults and adolescents.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.